Ownership history in XTX Topco Ltd · 9 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ORAMED PHARMACEUTICALS INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 38,182 | +14,297 | +59.9% | 0.00% | $109K | $2.66 |
| 2025 Q3 | REDUCED | 23,885 | -831 | -3.4% | 0.00% | $63K | $2.46 |
| 2024 Q3 | ADDED | 24,716 | +9,242 | +59.7% | 0.00% | $60K | $2.27 |
| 2024 Q2 | REDUCED | 15,474 | -1,851 | -10.7% | 0.00% | $40K | $2.40 |
| 2023 Q4 | REDUCED | 17,325 | -134,295 | -88.6% | 0.01% | $40K | $2.15 |
| 2023 Q1 | ADDED | 151,620 | +94,537 | +165.6% | 0.07% | $331K | $2.03 |
| 2022 Q4 | ADDED | 57,083 | +38,909 | +214.1% | 0.15% | $687K | $11.21 |
| 2022 Q2 | ADDED | 18,174 | +7,618 | +72.2% | 0.03% | $83K | $4.27 |
| 2021 Q4 | INITIATED | 10,556 | — | — | 0.09% | $151K | $13.31 |
As of 2025 Q4 — sorted by position size